FIELD: medicine.
SUBSTANCE: thoracocentesis is performed followed by cavity flushing with aseptic solution and active aspiration. Further sanitated pleuropulmonary cavity is filled by 1/3 of its volume by antiseptic fluid including 1.7 ml of 33% hydrogen peroxide solution, 0.8 ml of 85% formic acid solution and up to 100 ml of glycerin. Then this solution is exposed until overflow feeling appears, and fluid volume accumulated in pleuropulmonary cavity is removed.
EFFECT: accelerated removal of necrotic areas and pus from purulent pleuropulmonary cavity without side effects and complications due to multidirectional effect of the solution components.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD TO TREAT PURULENT PLEUROPULMONARY CAVITY | 1993 |
|
RU2103040C1 |
METHOD FOR TREATING THE PURULENT PNEUMOPULMONARY CAVITIES | 0 |
|
SU1683696A1 |
METHOD FOR TREATMENT OF NONSPECIFIC LIMITED PLEURAL EMPYEMA AND DEVICE FOR ITS IMPLEMENTATION | 2016 |
|
RU2644290C2 |
METHOD OF FRACTIONAL DRAINANGE OF PLEURAL SPACE AND RELATED DEVICE FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2402354C1 |
OINTMENT FOR TREATMENT OF SCARS | 2005 |
|
RU2281084C1 |
OINTMENT FOR OPEN WOUND TREATMENT | 1993 |
|
RU2082394C1 |
OINTMENT FOR TREATMENT OF DEGENERATIVE-DYSTROPHIC DISEASES OF LOCOMOTOR SYSTEM | 2005 |
|
RU2304429C2 |
METHOD FOR TREATING PURULENT CAVITIES WITH CONTROLLED DRAINAGE | 1996 |
|
RU2106884C1 |
OINTMENT FOR TREATING BURN WOUNDS | 2005 |
|
RU2287324C1 |
METHOD FOR OESOPHAGEAL ANAESTHESIA PRECEDING BOUGIENAGE | 2011 |
|
RU2479309C1 |
Authors
Dates
2009-01-27—Published
2007-05-23—Filed